Status:
COMPLETED
Combatting Social Isolation in Older Adults
Lead Sponsor:
Florida State University
Collaborating Sponsors:
Retirement Research Foundation
Conditions:
Loneliness
Social Isolation
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Increasing evidence suggests that perceived social isolation and loneliness are major risk factors for physical and mental illness in later life. The prevalence of loneliness in US older adults warran...
Detailed Description
The study design involves protocol refinement and clinical trial evaluation phases: 1. Refinement. The first phase of this proposal involves refining our existing protocol - "Combating Social Isolati...
Eligibility Criteria
Inclusion
- Access to text message reminders
- Elevated loneliness (i.e. higher than a score of 5 on the Hughes et al., 2004, Short Scale for Measuring Loneliness in Large Surveys)
- Treatment stability will be required in terms of both psychopharmacology (2 month stable dose) as well as psychotherapy (2 months of ongoing treatment).
Exclusion
- Evidence of significant medical conditions including visual, auditory or cognitive impairments that would prevent comprehension of the intervention materials.
- Participants who change medications or initiate psychotherapy during the follow-up interval will be evaluated separately and potentially excluded from the main analyses.
Key Trial Info
Start Date :
July 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05426837
Start Date
July 30 2022
End Date
July 1 2024
Last Update
February 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anxiety and Behavioral Health Clinic
Tallahassee, Florida, United States, 32306